Darwin Global Management, Ltd
$3.8B 13F equity value
6 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Darwin Global Management, Ltd covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 10,629,822 | $2.0B | 54.5% |
| INSM | INSMED INC | 6,431,163 | $674M | 17.9% |
| BLTE | BELITE BIO INC | 3,077,219 | $457M | 12.1% |
| ABVX | ABIVAX SA | 3,621,583 | $348M | 9.3% |
| ROIV | ROIVANT SCIENCES LTD | 6,747,300 | $234M | 6.2% |
| DNTH | DIANTHUS THERAPEUTICS INC |
Track Darwin Global Management, Ltd's 13F portfolio: $3.8B in reported holdings, 6 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}